These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 12198247

  • 1. Angiotensin II subtype 2 receptor activation inhibits insulin-induced phosphoinositide 3-kinase and Akt and induces apoptosis in PC12W cells.
    Cui TX, Nakagami H, Nahmias C, Shiuchi T, Takeda-Matsubara Y, Li JM, Wu L, Iwai M, Horiuchi M.
    Mol Endocrinol; 2002 Sep; 16(9):2113-23. PubMed ID: 12198247
    [Abstract] [Full Text] [Related]

  • 2. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
    Batty IH, Fleming IN, Downes CP.
    Biochem J; 2004 May 01; 379(Pt 3):641-51. PubMed ID: 14769130
    [Abstract] [Full Text] [Related]

  • 3. Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor.
    Elbaz N, Bedecs K, Masson M, Sutren M, Strosberg AD, Nahmias C.
    Mol Endocrinol; 2000 Jun 01; 14(6):795-804. PubMed ID: 10847582
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II blocks nicotine-mediated neuroprotection against beta-amyloid (1-42) via activation of the tyrosine phosphatase SHP-1.
    Shaw S, Bencherif M, Marrero MB.
    J Neurosci; 2003 Dec 03; 23(35):11224-8. PubMed ID: 14657181
    [Abstract] [Full Text] [Related]

  • 5. Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation.
    Kruszynska YT, Worrall DS, Ofrecio J, Frias JP, Macaraeg G, Olefsky JM.
    J Clin Endocrinol Metab; 2002 Jan 03; 87(1):226-34. PubMed ID: 11788651
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
    Andreozzi F, Laratta E, Sciacqua A, Perticone F, Sesti G.
    Circ Res; 2004 May 14; 94(9):1211-8. PubMed ID: 15044323
    [Abstract] [Full Text] [Related]

  • 7. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.
    Uddin S, Majchrzak B, Wang PC, Modi S, Khan MK, Fish EN, Platanias LC.
    Biochem Biophys Res Commun; 2000 Apr 02; 270(1):158-62. PubMed ID: 10733921
    [Abstract] [Full Text] [Related]

  • 8. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ, O'Rourke DM, Feng GS, Johnson GR, Wang Q, Greene MI.
    Oncogene; 2001 Sep 20; 20(42):6018-25. PubMed ID: 11593409
    [Abstract] [Full Text] [Related]

  • 9. Galphaq/11 signaling induces apoptosis through two pathways involving reduction of Akt phosphorylation and activation of RhoA in HeLa cells.
    Ueda H, Morishita R, Narumiya S, Kato K, Asano T.
    Exp Cell Res; 2004 Aug 01; 298(1):207-17. PubMed ID: 15242775
    [Abstract] [Full Text] [Related]

  • 10. In vivo activation of insulin receptor tyrosine kinase by melatonin in the rat hypothalamus.
    Anhê GF, Caperuto LC, Pereira-Da-Silva M, Souza LC, Hirata AE, Velloso LA, Cipolla-Neto J, Carvalho CR.
    J Neurochem; 2004 Aug 01; 90(3):559-66. PubMed ID: 15255933
    [Abstract] [Full Text] [Related]

  • 11. Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell.
    Cui T, Nakagami H, Iwai M, Takeda Y, Shiuchi T, Daviet L, Nahmias C, Horiuchi M.
    Cardiovasc Res; 2001 Mar 01; 49(4):863-71. PubMed ID: 11230986
    [Abstract] [Full Text] [Related]

  • 12. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
    Ozes ON, Akca H, Mayo LD, Gustin JA, Maehama T, Dixon JE, Donner DB.
    Proc Natl Acad Sci U S A; 2001 Apr 10; 98(8):4640-5. PubMed ID: 11287630
    [Abstract] [Full Text] [Related]

  • 13. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle.
    Kim YB, Zhu JS, Zierath JR, Shen HQ, Baron AD, Kahn BB.
    Diabetes; 1999 Feb 10; 48(2):310-20. PubMed ID: 10334307
    [Abstract] [Full Text] [Related]

  • 14. nitric oxide triggers the phosphatidylinositol 3-kinase/Akt survival pathway in insulin-producing RINm5F cells by arousing Src to activate insulin receptor substrate-1.
    Tejedo JR, Cahuana GM, Ramírez R, Esbert M, Jiménez J, Sobrino F, Bedoya FJ.
    Endocrinology; 2004 May 10; 145(5):2319-27. PubMed ID: 14764634
    [Abstract] [Full Text] [Related]

  • 15. The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase.
    Marrero MB, Papke RL, Bhatti BS, Shaw S, Bencherif M.
    J Pharmacol Exp Ther; 2004 Apr 10; 309(1):16-27. PubMed ID: 14722323
    [Abstract] [Full Text] [Related]

  • 16. Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems.
    Calegari VC, Alves M, Picardi PK, Inoue RY, Franchini KG, Saad MJ, Velloso LA.
    Endocrinology; 2005 Feb 10; 146(2):579-88. PubMed ID: 15514089
    [Abstract] [Full Text] [Related]

  • 17. The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance.
    Carvalheira JB, Calegari VC, Zecchin HG, Nadruz W, Guimarães RB, Ribeiro EB, Franchini KG, Velloso LA, Saad MJ.
    Endocrinology; 2003 Dec 10; 144(12):5604-14. PubMed ID: 12960006
    [Abstract] [Full Text] [Related]

  • 18. Reciprocal feedback regulation of insulin receptor and insulin receptor substrate tyrosine phosphorylation by phosphoinositide 3-kinase in primary adipocytes.
    Hers I, Bell CJ, Poole AW, Jiang D, Denton RM, Schaefer E, Tavaré JM.
    Biochem J; 2002 Dec 15; 368(Pt 3):875-84. PubMed ID: 12220227
    [Abstract] [Full Text] [Related]

  • 19. Interaction of insulin receptor substrate-1 (IRS-1) with phosphatidylinositol 3-kinase: effect of substitution of serine for alanine in potential IRS-1 serine phosphorylation sites.
    Delahaye L, Mothe-Satney I, Myers MG, White MF, Van Obberghen E.
    Endocrinology; 1998 Dec 15; 139(12):4911-9. PubMed ID: 9832428
    [Abstract] [Full Text] [Related]

  • 20. Insulin substrates 1 and 2 are corequired for activation of atypical protein kinase C and Cbl-dependent phosphatidylinositol 3-kinase during insulin action in immortalized brown adipocytes.
    Miura A, Sajan MP, Standaert ML, Bandyopadhyay G, Kahn CR, Farese RV.
    Biochemistry; 2004 Dec 14; 43(49):15503-9. PubMed ID: 15581362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.